Novartis takes aim at Roche’s star MS drug
ZURICH (Reuters) – Swiss drugmaker Novartis on Friday stepped up its challenge to Roche’s multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its…
by October Gallery
ZURICH (Reuters) – Swiss drugmaker Novartis on Friday stepped up its challenge to Roche’s multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its…
“Today is a banner day,” the actress wrote on Instagram Thursday with a photo showing her in what appears to be a hospital room. “I am being discharged from the…
FILE PHOTO: The logo for Biohaven Pharmaceutical Holding Company is displayed on a screen during the company’s IPO on the floor of the New York Stock Exchange (NYSE) in New…
Selma Blair made her first public appearance Sunday night at the Vanity Fair Oscar party, months after being diagnosed with multiple sclerosis last year. The “Legally Blonde” actress wrote about…
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin a clinical trial of its experimental stem cell treatment in…
“I am disabled,” the “Legally Blonde” and “Cruel Intentions” star wrote in her post. “I fall sometimes. I drop things. My memory is foggy. And my left side is asking…